Post Marketing Surveillance Study to Observe Safety and Efficacy of Inlyta in South Korea

POST MARKETING SURVEILLANCE STUDY TO OBSERVE SAFETY AND EFFICACY OF INLYTA (REGISTERED)

The objective of this study is to monitor the usage of INLYTA® in real practice, including the adverse events associated with INLYTA®.

Investigators can choose any patient who is within the scope of I/E criteria

Inclusion Criteria:

• Patients diagnosed as advanced RCC after failure of one prior systemic therapy.

Exclusion Criteria:

• Any patient who does not agree that Pfizer or companies working on behalf of Pfizer can use his/her information.
• Patients with hypersensitivity to axitinib or to any other component of INLYTA® .
• Patients under 18.
• Pregnant women.